Related Experiment Video
Updated: Mar 25, 2026
07:55
Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment
Published on: September 25, 2017
8.4K
Peptide mini-scaffold facilitates JNK3 activation in cells
Xuanzhi Zhan1, Henriette Stoy1,2, Tamer S Kaoud3,4
1Departments of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA.
Scientific Reports
|February 13, 2016
Summary
A small arrestin-3 peptide acts as the smallest known mitogen-activated protein kinase (MAPK) scaffold, enhancing JNK3 activity and influencing cell death. This discovery offers potential therapeutic targets for MAPK-related diseases.
Area of Science:
- Cellular Biology
- Molecular Signaling
- Biochemistry
Background:
- Mitogen-activated protein kinase (MAPK) signaling cascades are crucial in eukaryotic cells.
- Scaffold proteins organize these MAPK cascades into functional signaling complexes.
- Arrestin-3 is known to facilitate JNK activation, with a specific peptide identified as a key JNK3-binding element.
Purpose of the Study:
- To investigate the binding interactions of the arrestin-3 peptide with upstream JNK3-activating kinases.
- To determine if the arrestin-3 peptide can enhance JNK3 activity.
- To compare the scaffolding activity of arrestin-3 and arrestin-2 peptides.
Main Methods:
- Peptide binding assays to identify interactions with MKK4, MKK7, and ASK1.
- Cell-based assays to assess the effect of the arrestin-3 peptide on JNK3 activity.
- Comparative analysis of arrestin-3 and arrestin-2 peptide functionalities.
Main Results:
- The arrestin-3 peptide binds to MKK4, MKK7, and ASK1, upstream kinases that activate JNK3.
- This peptide is sufficient to enhance JNK3 activity in cellular contexts.
- A homologous arrestin-2 peptide showed limited binding and no enhancement of JNK3 activation, highlighting the specificity of arrestin-3.
Conclusions:
- The arrestin-3 peptide represents the smallest known MAPK scaffold.
- This peptide can modulate MAPK activity, impacting cellular fate decisions like apoptosis.
- Arrestin-3 peptides or their mimics hold potential for regulating MAPK signaling pathways.
Related Concept Videos
01:07MAPK Signaling Cascades
9.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.2K
01:20The JAK-STAT Signaling Pathway
13.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.8K
01:22Amplifying Signals via Enzymatic Cascade
19.2K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.2K
01:22PI3K/mTOR/AKT Signaling Pathway
6.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.2K
01:25cAMP-dependent Protein Kinase Pathways
9.2K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
9.2K
01:30Assembly of Signaling Complexes
7.1K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
7.1K